Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

NCT02465476 | Completed

• 1 other identifier: RC31/13/6901
• Study Type: interventional
• Target: 212
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators want to demonstrate that a new organization with telemedicine could rationalize the treatment pathway of patient suffering from rare skin disease. A diagnosis and a personalised treatment pathway could be performed before the consultation in the hospital.

Conditions

Skin Disease

Keywords

skin disease; telemedicine

Outcome Measures

Primary Outcomes (1)

• Number of hospital visits

  Interest of a procedure of telemedicine on the organization of the treatment pathway of patients affected by rare skin diseases in terms of change of the number of visit in hospital.

  6 months

Secondary Outcomes (4)

• Improvement of the treatment pathway and its organization

  6 months

• Satisfaction of the patient

  6 months

• Change of the cost related to the patient care (direct and indirect).

  6 months

• management of time by the medical personal.

  6 months

Study Arms (2)

normal care

NO INTERVENTION

patient who will have normal treatment pathway

telemedicine

EXPERIMENTAL

patient who will have telemedicine

Procedure: telemedicine

Interventions

telemedicine PROCEDURE

treatment pathway organized by telemedicine

telemedicine

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• New patients suffering from a rare skin disease whatever pathology or age, which needs a take-over by this centre
• Or patients already take-over by the centre but lost to follow-up for more than one year
• Patients (and/or parents) who give their consents
• Patients (and/or parents) able to fill in questionnaires

You may not qualify if:

• Pregnant or breast-feeding women.
• Patients subject to a judicial safeguard order
• Patients who need an emergency take-over
• Patients followed by a doctor who does not have a computerized system or refuse to send data via the secured messaging

Sponsors & Collaborators

• University Hospital, Toulouse: lead

Study Sites (1)

UHToulouse

Toulouse, 31059, France

Location

MeSH Terms

Conditions

Skin Diseases

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Delivery of Health Care; Patient Care Management; Health Services Administration

Study Officials

• Juliette Mazereeuw-Hautier, MD . PHD

  University Hospital, Toulouse

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 24, 2015
• First Posted: June 8, 2015
• Study Start: January 6, 2015
• Primary Completion: May 30, 2018
• Study Completion: May 30, 2018
• Last Updated: November 20, 2018

Record last verified: 2018-11

Locations

FR (1)